DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and …
Over the last 12 months, insiders at DarioHealth Corp. have bought $66,745 and sold $0 worth of DarioHealth Corp. stock.
On average, over the past 5 years, insiders at DarioHealth Corp. have bought $46,056 and sold $1.35M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Nelson Steven Charles (Chief Commercial Officer) — $43,965. Raphael Erez (Chief Executive Officer) — $22,780.
The last purchase of 5,000 shares for transaction amount of $4,023 was made by Nelson Steven Charles (Chief Commercial Officer) on 2024‑09‑11.
2024-09-11 | Chief Commercial Officer | 5,000 0.017% | $0.80 | $4,023 | +3.14% | |||
2024-09-10 | Chief Commercial Officer | 5,000 0.0179% | $0.84 | $4,221 | +27.02% | |||
2024-09-09 | Chief Commercial Officer | 5,000 0.0163% | $0.80 | $4,000 | +22.55% | |||
2024-09-06 | Chief Commercial Officer | 5,000 0.0168% | $0.84 | $4,201 | +19.76% | |||
2024-09-05 | Chief Commercial Officer | 5,000 0.017% | $0.82 | $4,091 | +25.00% | |||
2024-08-27 | Chief Executive Officer | 5,000 0.0172% | $0.88 | $4,400 | +13.86% | |||
2024-08-23 | Chief Commercial Officer | 5,000 0.017% | $0.95 | $4,750 | +3.29% | |||
2024-08-22 | Chief Commercial Officer | 5,000 0.0173% | $0.94 | $4,725 | +4.91% | |||
2024-08-21 | Chief Executive Officer | 5,000 0.017% | $0.95 | $4,750 | +2.27% | |||
2024-08-21 | Chief Commercial Officer | 5,000 0.0167% | $0.93 | $4,673 | +2.27% | |||
2024-08-20 | Chief Executive Officer | 5,000 0.0168% | $0.93 | $4,650 | +3.16% | |||
2024-08-20 | Chief Commercial Officer | 5,000 0.017% | $0.94 | $4,685 | +3.16% | |||
2024-08-19 | Chief Executive Officer | 5,000 0.0157% | $0.90 | $4,500 | -0.61% | |||
2024-08-19 | Chief Commercial Officer | 5,000 0.0161% | $0.92 | $4,599 | -0.61% | |||
2024-08-16 | Chief Executive Officer | 5,000 0.0157% | $0.90 | $4,480 | -0.01% | |||
2023-05-04 | director | 50 – | $3.37 | $169 | -39.59% | |||
2023-05-04 | director | 40 – | $3.37 | $135 | -39.59% | |||
2023-05-04 | Chief Executive Officer | 30 – | $3.37 | $101 | -39.59% | |||
2023-05-04 | director | 30 – | $3.37 | $101 | -39.59% | |||
2023-01-13 | Sale | Chief Executive Officer | 1,200 0.0053% | $6.21 | $7,449 | -40.24% |
Raphael Erez | Chief Executive Officer | 1937059 6.184% | $0.98 | 23 | 8 | +359.67% |
Nelson Steven Charles | Chief Commercial Officer | 50000 0.1596% | $0.98 | 10 | 0 | |
Farhi Shmuel | 10 percent owner | 329742 1.0527% | $0.98 | 1 | 0 | |
STERN ADAM K | director | 69341 0.2214% | $0.98 | 17 | 0 | +113.81% |
Karah Hila | director | 49143 0.1569% | $0.98 | 11 | 0 | <0.0001% |
Nantahala Capital Management Llc | $4.03M | 8.8 | 2.63M | +12.66% | +$452,583.26 | 0.19 | |
Appian Way Asset Management LP | $2.04M | 4.46 | 1.33M | +0.89% | +$17,897.94 | 0.67 | |
Y D More Investments Ltd | $1.84M | 4.02 | 1.2M | -6.66% | -$131,254.08 | 0.25 | |
Phoenix Holdings Ltd | $1.81M | 3.95 | 1.18M | 0% | +$0 | 0.03 | |
Clal Insurance Enterprises Holdings Ltd | $1.07M | 2.33 | 698,362 | -20.27% | -$271,605.47 | 0.01 |